Laura Gover, Andrew Anguko, Jane Bruce, Godfrey Magumba, et al.
1
Lee, V.
1
Lenzen, M.
1
Leon-Velarde, F.
1
Lesotho National AIDS Commission, Government of Lesotho
1
Llyod, A.
1
London School of Hygiene and Tropical Medicine
1
López, L.
1
Lucinda Ramos
1
Lukito, A.A., A.U. Rahajoe, L.I. Rilantono, et al.,
1
M. A. Babu
1
M. B. Mello
1
M. Bertram et al.
1
M. Doara, D. Choroliani, P. de Colombani
1
M. Doherty
1
M. F. Silveira
1
M. Gallardo, et al.
1
M. Holtmann
1
M. Joffres
1
M. Kan
1
M. M. Ahmmed
1
M. Odhiambo Sewe, A.M Tompkins et al.
1
M. Penazzato
1
M. Semrau
1
M. Smelyanskaya, J. Duncan
1
M. Sundararaj
1
M. Vitoria
1
M.C. Mollo, et al.
1
M.Johnson
1
M.N. Ngongondo
1
Machalaba
1
MacQuarrie, Kerry L.D., Rebecca Winter, and Sunita Kishor
1
MacQuarrie, Kerry L.D., Sarah E.K. Bradley, Alison Gemmill, and Sarah Staveteig
1
Magitta, N.F.
1
Mailloux, N.A. et al.
1
Mairie de Paris
1
Makatjane, T. J., T. Hlabana, and E. M. Letete
1
Malaria Consortium
1
Malik, A. A.
1
Mangwiro, TNC.
1
March of Dimes
1
Mark W. Rosegrant | Jawoo Koo | Nicola Cenacchi
1
Marselle M., Stadler J., Korn H., et al.
1
Martinez, L.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
Mary De Silva, Lucy Lee& Grace Ryan
1
Mary-Anne Hartley, Alyssa Young, Anh-Minh Tran et al.
1
Marzouk M., Rayes D., Y. Douedari et al.
1
Massoda Tonye, S.G.
1
Matsushita, K.
1
Maurice Bucagu, Jean M. Kagubare, Paulin Basinga, Fidèle Ngabo, Barbara K Timmons & Angela C Lee
1
McCullagh S, Hunter B, Houle K et al.
1
McGahey, Christopher
1
McGloin, J.
1
MCNV, Global Initiative on Psychiatry, and World Granny
1
Mediscript Ltd
1
Melanie Duncan, et al.
1
Mensah, G.A.
1
Mental, Neurological, and Substance Use Disorders: Disease Control Priorities, Third Edition (Volume 4).
1
Meyfroidt, P.
1
Médecins Sans Frontières (MSF)
1
Médecins sans Frontières MSF
1
mhGAP
1
Michael T. Osterholma, Kristine A. Moorea, Nicholas S. Kelley et al.
1
Miller, C.
1
Ministerio de sanidad - España
1
Ministry of Health & Child Welfare
1
Ministry of Health & Family Welfare, India, et al.
1
Ministry of Health and Family Welfare Government of India
1
Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh
1
Ministry of Health and Family Welfare, Directorate-General of Health Services, Mycobacterial Disease Control, National Tuberculosis Control Programme
1
Ministry of Health and Social Services (MOHSS)
1
Ministry of Health and Social Welfare, Government of India
1
Ministry of Health Ethiopia
1
Ministry of Health, Gabarone, Botswana
1
Ministry of Health, Ghana
1
Ministry of Health, Pakistan
1
Ministry of Health, Republic of South Africa
1
Ministry of Health, Republic of Uganda
1
Ministry of Health, South Africa
1
Ministry of Health, Uganda
1
Ministry of Health, Zambia
1
Ministry of Public Health, Quatar
1
Minja, N.W.
1
Mock C. N., Nugent R. et. al.
1
Mock, Charles N.
1
Mohammed A. , Putnis N. et al.
1
Monnier, N.
1
Mont, D.
1
Montelongo, A.
1
Moo-llanes, D.
1
Mortimer, K.
1
Moses, M.W.
1
MSF Access Campaign
1
MSMGF
1
Mukaratirwa, S. et al.
1
Murray, C.J.L.
1
Mutale W.
1
Myanmar Climate Change Alliance (MCCA)
1
Myanmar, Ministry of Health and Sports
1
N. Abera, T. Saballa, et al.
1
N. B. Ahmed
1
N. K. Arora
1
N.I. Agudelo Higuita, S.A. Hamer, et al.
1
NACO, Department of AIDS Control
1
Nakagaayi, D.
1
NASCOP
1
Nat Commun 13, 2788 (2022)
1
National Academy of Sciences of the USA
1
National Agency for Control of AIDS (NACA)
1
National AIDS
1
National AIDS Control Program
1
National AIDS Secretariat
1
National Department of Health South Africa
1
National HIVAIDS Council Zambia
1
National Institute of Disaster Management (NIDM), Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)
1
National Institute of Environmental Health Sciences
1
National Malaria Elimination Centre, Ministry of Health, Zambia
1
National TB Control Programme, Bangladesh
1
Nature Communications
1
nature medicine
1
Nature Scientific Reports
1
Ncube, M.
1
ndia State-Level Disease Burden Initiative Cancer Collaborators
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Net Hope
1
Niederberger, E.
1
Norwegian Red Cross
1
Norwegian Refugee Council, Internal Displacement Monitoring Centre
1
Nouvellet, P.
1
Nove A., Friberg I., de Bernis L., et al.
1
NSW Health and University of Western Sydney
1
Nugent, Rachel
1
Nunn, Marc
1
Nunziata, K. R.
1
O. Hanssen
1
O. Samoylova
1
O. T. Ranzani
1
OECD
1
Office for the Coordination of Humanitarian Affairs OCHA
1
Oliveira, R.G. de.
1
Olney, Jack J.
1
OMS (WHO)
1
ONUSIDA
1
Organización Mundial de Saude and OPAS
1
Organização Mundial da Saúde (OMS)
1
Ouédraogo M., Samadoulougou S., Rouamba T. et. al.
This document aims to describe a minimum set of surveillance activities recommended at the national level to detect and monitor the relative prevalence of SARS-CoV-2 variants and outline a set of activities for the characterization and assessment of risk posed by these variants. A set of indicators ...is also provided to standardize monitoring and public reporting of variant circulation.
The document is primarily intended for national and sub-national public health authorities and partners who support implementation of surveillance for SARS-CoV-2 variantsmore
The guide is divided into 3 sections —the first focuses on the conceptual framework for M&E; the second focuses on six key steps for M&E; and further, the appendix provides additional tools, resources, and projects for M&E. With a comprehensive breakdown of the important approaches as well as a ch...ecklist approach to the setting up of a monitoring and evaluation framework, this guide works for almost everyonemore
The Core Set of Indicators and respective Indicator Data Sheets aim to pave the way towards a common understanding, greater consistency and comparability across countries and alignment of results chains of German Development Cooperation in the field of health and social health protection with the in...ternationally recognized health systems framework of WHO and International Health Partnership (IHP+).more
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in... order to make evidence-based decisions on the most appropriate control measures for each specific situation. IVM can be used for surveillance and control or for elimination of VBDs and can help reduce the development of insecticide resistance through the rational use of these products. This document provides instructions for fulfillment of the 2008 PAHO mandate set forth in CD 48/13 (Integrated Vector Management).more
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems’ ability to prov...ide population-wide access to essential medicines.
Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products.
This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.more
Weekly epidemiological recordRelevé épidémiologique hebdomadaire 3 MAY 2024, 99th YEAR / 3 MAI 2024, 99e ANNÉE
No 18, 2024, 99, 203–224
The WHO position papers are concerned primarily with the use of vaccines in large-scale vaccination programmes.
The position papers are intended for use by... national public health officials and managers of immunization programmes.
This paper focuses on the second licensed dengue vaccine, TAK-003 (Qdenga, Takeda), along with WHO’s position for its use, and provides an update on the first licensed dengue vaccine, CYD-TDV.more
he WHO South-East Region in 2019 accounted for nearly a million missing TB patients from the estimated incidence. Active case-finding (ACF) or systematic screening for tuberculosis is an important tool to reach out to missing TB patients. When appropriately implemented, the activity is cost effectiv...e, helps to reduce diagnosis and treatment delays, and prevents the spread of the disease. This document presents an analysis of published ACF studies from the Region. It can be used by Member States for effective planning, implementation and monitoring of these activities.more
This guide is a revised edition to the previous version published in 2017.
This updated publication provides programme managers with a user-friendly tool that can: (i) analyse and draw conclusions from historic dengue datasets; (ii) identify appropriate alarm indicators that can predict forthcoming... outbreaks at smaller spatial scales; and (iii) use these results and analyses to build an early warning system to detect dengue outbreaks in real time and respond accordingly. This web-based tool can ensure enhanced, fast and secured communication between national and subnational levels, and standardized utilization of surveillance data.more
This recommendation is an update of one of the 49 recommendations that were published in the WHO recommendations on antenatal care for a positive pregnancy experience. The recommendation was developed initially using the standardized operating procedures described in the WHO handbook for guideline d...evelopment.
In summary, the process included: (i) identification of priority question and outcomes; (ii) retrieval of evidence; (iii) assessment and synthesis of the evidence; (iv) formulation of recommendation; and (v) planning for the implementation, dissemination, impact evaluation and updating of the recommendation. This recommendation was identified by the Executive Guideline Steering Group (GSG) as a high priority for updating in response to new evidence on this question.more
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...O’s Thirteenth General Programme of
Work 2019–2023 (GPW13). This checklist was developed by the WHO Secretariat of Evidence-Informed Policy Network (EVIPNet) to assist its Member countries in institutionalizing EIPM. Government agencies (i.e. the staff of the Ministry of Health),
knowledge intermediaries and researchers focused on strengthening EIPM will find in this checklist some key steps and tools to help their work. While the health sector is a key target group for EVIPNet, this tool can be applied by stakeholders from
different social sectorsmore
A. Pharris; A. StengaardWorld Health Organization (Europe); European Centre for Disease Prevention and Control
(2017)
C_WHO
2016 data
The report was coordinated by Anastasia Pharris and Annemarie Stengaard.
Report review and production support were provided by Andrew J. Amato-Gauci, Mike Catchpole, Denis Coulombier, Masoud Dara, Nedret Emiroglu, Rachel Katterl, Shahin Khasiyev, Valentina Lazdina, Teymur Noori, Marc... Rondy, Chantal Quintin, Phillip Zucs.more
Health ministries currently lack effective tools for monitoring and evaluation of schistosomiasis control programmes. Egg detection can be used, but the cost, challenges of obtaining samples, and the need for trained personnel and equipment limit the frequency of monitoring. The purpose of this TPP ...is to guide the development of new diagnostic tools to reliably measure when prevalence is above or below a cut-off of 10% in school-aged children. Communities remaining above 10% require annual MDA, while communities below 10% can reduce MDA frequency as long as < 10% prevalence can be maintained. However, the lack of a reliable test has hindered the development of maintenance strategies. The test is also needed to track changes of prevalence > 10% to ensure that annual MDA is reducing overall prevalence.more
Long-lasting insecticidal nets (LNs) constitute a core vector control intervention against malaria. A number of new LN products are under development and will require assessment of risks to humans. This document provides an updated generic model that can be used for the risk assessment of exposure t...o insecticides of individuals sleeping under LNs and during the washing of nets.
In an Annex, exposures and health risks are described for the conventional treatment or retreatment of nets (ITNs) with an insecticide considering that such practices may still be used in evaluation of ITNs and their use. The generic model does not include the risks associated with the manufacturing of LNs in a factory environment.more